跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SERENACE haloperidol 20 mg/2 mL injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
SERENACE haloperidol 20 mg/2 mL injection ampoule
Approved
STANDARD
SERENACE haloperidol 20 mg/2 mL injection ampoule
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b4ea1755eaaba0bc
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
b4ea1755eaaba0bc
Product Name
SERENACE haloperidol 20 mg/2 mL injection ampoule
Artg Id
10260
Artg Name
SERENACE haloperidol 20 mg/2 mL injection ampoule
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
1991-08-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-PI-02397-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b4ea1755eaaba0bc
Type
Standard
Back to TGA Approvals